media-34-stamford-advocate-natalis

STAMFORD ADVOCATE | 03.11.18

Sema4 Aims to Advance Newborn Testing With Latest Product

“Newborns in the U.S. are usually tested for about three dozen diseases. But that number only scratches the surface of potential illnesses, says genomic-testing firm Sema4. Aiming to fill the gaps between the scope of traditional tests and the thousands of disorders that can afflict young children, Stamford-based Sema4 launched last month an at-home test for 193 conditions that manifest in childhood…”